Joenja® (leniolisib) – New orphan drug approval
March 24, 2023 - Pharming announced the FDA approval of Joenja (leniolisib), for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adult and pediatric patients 12 years of age and older.
Download PDF
